Inst. Holders
1 funds
SMNR
Semnur Pharmaceuticals, Inc.
$0.4500 ▼ -21.05%
Prev close $0.5700 Biotech & Drug Discovery
Snapshot
The big-picture read on SMNR right now — valuation, ownership and activity at a glance.
Inst. Value
$15.00
SEC Reports
1
Price chart 30d -18.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 14, 2026 earnings_calendar
Jul 7, 2026 SEC SMNR Q2 2026 Earnings Scheduled — 2026-08-14
Semnur Pharmaceuticals signed a binding term sheet with iHolding Group LLP for a $100M investment at $10/share, issuing
8-K — Impact 5/10
Jun 15, 2026 Insider
Scilex Holding Co disposed of 7,034,737 shares
10%+ Owner
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
1 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 1 neutral · avg impact 5.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 14, 2026
earnings_calendar
SMNR Q2 2026 Earnings Scheduled — 2026-08-14
May 11, 2026
earnings_calendar
SMNR Q1 2026 Earnings Scheduled — 2026-05-11
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own SMNR (from quarterly 13F filings) and who is adding or trimming.
1 institutional holders with $15.00 total value (30 shares) as of 2026-Q2. Top holders: RHUMBLINE.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | $15.00 | 100.0% | — |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
1 insiders, 1 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Scilex Holding Co | 10%+ Owner | J | 7,034,737 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SMNR.
Shares short
91,953
Settlement Sep 15, 2026
Change vs prior
0.0%
Semi-monthly cycle
Days to cover
10.9
At avg daily volume
All SMNR filing & press-release reports (1)
- 8-K reportJul 7, 2026